CD47 and neoplasm: Anti-CD47 mAb treatment was shown to increase in vitro macrophage phagocytosis, to inhibit tumor formation, and to enhance macrophage infiltration in xenograft model of ovarian clear cell adenocarcinoma (SKOV-3) (Figure 2A).